Tumor-Associated Fibronectin Targeted Liposomal Nanoplatform for Cyclophilin A siRNA Delivery and Targeted Malignant Glioblastoma Therapy

Malignant glioblastoma (GBM) is the most aggressive brain cancer that has a very low survival rate. With the rapid development of nanotechnology in the past few decades, the use of nanoparticles (NPs) for nucleic acid delivery is expected to have a revolutionary impact on GBM therapy. However, clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Saw, Phei Er, Zhang, Ao, Nie, Yan, Zhang, Lei, Xu, Yingjie, Xu, Xiaoding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199375/
https://www.ncbi.nlm.nih.gov/pubmed/30386245
http://dx.doi.org/10.3389/fphar.2018.01194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199375/
https://www.ncbi.nlm.nih.gov/pubmed/30386245
http://dx.doi.org/10.3389/fphar.2018.01194

Ejemplares similares